Skip to main content
. 2022 May 7;14(9):2320. doi: 10.3390/cancers14092320
ICIs Immune checkpoint inhibitors
LVGLS Left ventricular global longitudinal strain
CTRCD Cancer therapy-related cardiac dysfunction
LVEF Left ventricular ejection fraction
TDI Tissue Doppler imaging
ACIs Angiotensin-converting enzyme inhibitors
ARBs Angiotensin receptor blockers